2186 related articles for article (PubMed ID: 28555670)
1. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.
Nagarsheth N; Wicha MS; Zou W
Nat Rev Immunol; 2017 Sep; 17(9):559-572. PubMed ID: 28555670
[TBL] [Abstract][Full Text] [Related]
2. CCL7 Signaling in the Tumor Microenvironment.
Lee YS; Cho YB
Adv Exp Med Biol; 2020; 1231():33-43. PubMed ID: 32060844
[TBL] [Abstract][Full Text] [Related]
3. The chemokine network: a target in cancer biology?
Slettenaar VI; Wilson JL
Adv Drug Deliv Rev; 2006 Oct; 58(8):962-74. PubMed ID: 16996642
[TBL] [Abstract][Full Text] [Related]
4. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy.
Bule P; Aguiar SI; Aires-Da-Silva F; Dias JNR
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575965
[TBL] [Abstract][Full Text] [Related]
5. Chemokine systems in oncology: From microenvironment modulation to nanocarrier innovations.
Guan M; Liu S; Yang YG; Song Y; Zhang Y; Sun T
Int J Biol Macromol; 2024 May; 268(Pt 1):131679. PubMed ID: 38641274
[TBL] [Abstract][Full Text] [Related]
6. Improving homing in T cell therapy.
Vignali D; Kallikourdis M
Cytokine Growth Factor Rev; 2017 Aug; 36():107-116. PubMed ID: 28690108
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
8. Role of chemokine receptors in thyroid cancer and immunotherapy.
Coperchini F; Croce L; Marinò M; Chiovato L; Rotondi M
Endocr Relat Cancer; 2019 Aug; 26(8):R465-R478. PubMed ID: 31146261
[TBL] [Abstract][Full Text] [Related]
9. Chemokines in cancer.
Chow MT; Luster AD
Cancer Immunol Res; 2014 Dec; 2(12):1125-31. PubMed ID: 25480554
[TBL] [Abstract][Full Text] [Related]
10. Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor.
Li BH; Garstka MA; Li ZF
Mol Immunol; 2020 Jan; 117():201-215. PubMed ID: 31835202
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory chemokines and metastasis--tracing the accessory.
Borsig L; Wolf MJ; Roblek M; Lorentzen A; Heikenwalder M
Oncogene; 2014 Jun; 33(25):3217-24. PubMed ID: 23851506
[TBL] [Abstract][Full Text] [Related]
12. Natural products and their derivatives as immune check point inhibitors: Targeting cytokine/chemokine signalling in cancer.
Gupta M; Chandan K; Sarwat M
Semin Cancer Biol; 2022 Nov; 86(Pt 2):214-232. PubMed ID: 35772610
[TBL] [Abstract][Full Text] [Related]
13. Chemokine-chemokine receptors in cancer immunotherapy.
Stewart TJ; Smyth MJ
Immunotherapy; 2009 Jan; 1(1):109-27. PubMed ID: 20635978
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity.
Yano H; Andrews LP; Workman CJ; Vignali DAA
Immunology; 2019 Jul; 157(3):232-247. PubMed ID: 31087644
[TBL] [Abstract][Full Text] [Related]
15. Tumour-immune cell interactions modulated by chemokines.
Jöhrer K; Pleyer L; Olivier A; Maizner E; Zelle-Rieser C; Greil R
Expert Opin Biol Ther; 2008 Mar; 8(3):269-90. PubMed ID: 18294099
[TBL] [Abstract][Full Text] [Related]
16. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics and immunotherapy: The current state of play.
Dunn J; Rao S
Mol Immunol; 2017 Jul; 87():227-239. PubMed ID: 28511092
[TBL] [Abstract][Full Text] [Related]
18. Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy.
Vilgelm AE; Richmond A
Front Immunol; 2019; 10():333. PubMed ID: 30873179
[TBL] [Abstract][Full Text] [Related]
19. Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity.
D'Agostino G; Cecchinato V; Uguccioni M
Front Immunol; 2018; 9():2185. PubMed ID: 30319638
[TBL] [Abstract][Full Text] [Related]
20. Clinical utilization of chemokines to combat cancer: the double-edged sword.
Dell'Agnola C; Biragyn A
Expert Rev Vaccines; 2007 Apr; 6(2):267-83. PubMed ID: 17408375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
